FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2372401462> ?p ?o ?g. }

• W2372401462 endingPage "8" @default.
• W2372401462 startingPage "631" @default.
• W2372401462 abstract "To develop a parent-metabolite pharmacokinetic model for risperidone (RIP) and its major active metabolite (9-hydroxyrisperidone) and investigate their pharmacokinetics characteristics in healthy male volunteers, twenty-two healthy volunteers were orally given a single dose of 2 mg RIP. Plasma samples were collected in the period of 96 hours and concentrations of RIP and 9-hydroxyrisperidone were measured by a validated HPLC/MS method. CYP2D6 phenotypes were identified by the T1/2 of RIP and 9-hydroxyrisperidone according to the literature. Model structure identifiability analysis was performed by the similarity transformation approach to investigate whether the unknown parameters of the proposed model could be estimated from the designed experiment. Pharmacokinetics parameters were estimated using weighted least squares method, and the final pharmacokinetics model were tested and evaluated by Monte Carlo simulation. Eighteen volunteers were phenotyped as extensive metabolizers (EM) and four volunteers were identified as intermediate metabolizers (IM). The final model included central and peripheral compartment for both parent (RIP) and metabolite (9-hydroxyrisperidone) respectively. Model structure identifiability analysis indicated that the proposed model was local identifiable. However, if the ratio of RIP converted to 9-hydroxyrisperidone was assumed to be 32% in EM, and 22% in IM, the model could be globally identifiable. The predicted time-concentration curve and AUC(0-t), C(max), T(max) of RIP and 9-hydroxyrisperidone estimated by the established model were in agreement with the observations and noncompartment analysis. Rate constant of RIP conversion to 9-hydroxyrisperidone was (0.12 +/- 0.08) h(-1) and (0.014 +/- 0.007) h(-1) for EM and IM, respectively. Elimination rate constants of RIP were (0.25 +/- 0.18) and (0.05 +/- 0.23) h(-1) for EM and IM, respectively. Model validation result showed that all parameters derived from the concentration data fitted well with the theoretical value, with mean prediction error of most PK parameter within +/- 15%. The established model well defined the disposition of RIP and 9-hydroxyrisperidone simultaneously and showed large inter-individual pharmacokinetics variation in different CYP2D6 phenotype. The model also provide a useful approach to characterize pharmacokinetics of other parent-metabolite drugs." @default.
• W2372401462 created "2016-06-24" @default.
• W2372401462 creator A5024735954 @default.
• W2372401462 creator A5041420735 @default.
• W2372401462 creator A5057746033 @default.
• W2372401462 creator A5071342956 @default.
• W2372401462 date "2007-06-01" @default.
• W2372401462 modified "2023-09-23" @default.
• W2372401462 title "[Development and identifiability analysis of parent-metabolite pharmacokinetic model for risperidone and its main active metabolite 9-hydroxyrisperidone]." @default.
• W2372401462 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17702401" @default.
• W2372401462 hasPublicationYear "2007" @default.
• W2372401462 type Work @default.
• W2372401462 sameAs 2372401462 @default.
• W2372401462 citedByCount "0" @default.
• W2372401462 crossrefType "journal-article" @default.
• W2372401462 hasAuthorship W2372401462A5024735954 @default.
• W2372401462 hasAuthorship W2372401462A5041420735 @default.
• W2372401462 hasAuthorship W2372401462A5057746033 @default.
• W2372401462 hasAuthorship W2372401462A5071342956 @default.
• W2372401462 hasConcept C105795698 @default.
• W2372401462 hasConcept C112705442 @default.
• W2372401462 hasConcept C118552586 @default.
• W2372401462 hasConcept C122770356 @default.
• W2372401462 hasConcept C149151106 @default.
• W2372401462 hasConcept C185592680 @default.
• W2372401462 hasConcept C2776412080 @default.
• W2372401462 hasConcept C2777477808 @default.
• W2372401462 hasConcept C2780057945 @default.
• W2372401462 hasConcept C33923547 @default.
• W2372401462 hasConcept C55493867 @default.
• W2372401462 hasConcept C71924100 @default.
• W2372401462 hasConcept C98274493 @default.
• W2372401462 hasConceptScore W2372401462C105795698 @default.
• W2372401462 hasConceptScore W2372401462C112705442 @default.
• W2372401462 hasConceptScore W2372401462C118552586 @default.
• W2372401462 hasConceptScore W2372401462C122770356 @default.
• W2372401462 hasConceptScore W2372401462C149151106 @default.
• W2372401462 hasConceptScore W2372401462C185592680 @default.
• W2372401462 hasConceptScore W2372401462C2776412080 @default.
• W2372401462 hasConceptScore W2372401462C2777477808 @default.
• W2372401462 hasConceptScore W2372401462C2780057945 @default.
• W2372401462 hasConceptScore W2372401462C33923547 @default.
• W2372401462 hasConceptScore W2372401462C55493867 @default.
• W2372401462 hasConceptScore W2372401462C71924100 @default.
• W2372401462 hasConceptScore W2372401462C98274493 @default.
• W2372401462 hasIssue "6" @default.
• W2372401462 hasLocation W23724014621 @default.
• W2372401462 hasOpenAccess W2372401462 @default.
• W2372401462 hasPrimaryLocation W23724014621 @default.
• W2372401462 hasRelatedWork W1674319952 @default.
• W2372401462 hasRelatedWork W1870968175 @default.
• W2372401462 hasRelatedWork W1964759623 @default.
• W2372401462 hasRelatedWork W1972661330 @default.
• W2372401462 hasRelatedWork W1998356222 @default.
• W2372401462 hasRelatedWork W2007079254 @default.
• W2372401462 hasRelatedWork W2081460129 @default.
• W2372401462 hasRelatedWork W2127547864 @default.
• W2372401462 hasRelatedWork W2132691174 @default.
• W2372401462 hasRelatedWork W2611134831 @default.
• W2372401462 hasVolume "42" @default.
• W2372401462 isParatext "false" @default.
• W2372401462 isRetracted "false" @default.
• W2372401462 magId "2372401462" @default.
• W2372401462 workType "article" @default.